NEWS RELEASE                                                                                         October 2018

First Quarter 2019 Webinars will Focus on Biopharmaceuticals

In the first week of the new year we will have a webinar for investors and suppliers on process automation and will break out the booming biopharmaceutical segment. In succeeding weeks we will cover modular cleanrooms, pumps, valves, filtration, and centrifuges.

The pharmaceutical market will exceed $1 billion this year of which 80 percent will be synthetic pharmaceuticals. The global biopharmaceutical market will exceed $200 million this year and will double by 2025. In contrast the total pharmaceutical market will grow by less than 6 percent a year.

The biggest biopharmaceutical  growth segment will be monoclonal antibodies. The U.S.  biopharmaceutical market share is now 40 percent but will decrease slightly over the next five years. However the growth in the U.S. is likely to be above 8 percent.

January 9, 2019 - Guide, Control and Measure Markets and Structure

An analysis by McIlvaine will be the basis of a discussion of the market and shares of major suppliers who supply 30 percent of the market. The definitions and allocations of revenues for specific suppliers will be reviewed.  Potential participants are asked to review the analysis and make comments over the intervening period.  These comments will be reviewed and incorporated as appropriate. The analysis can be reviewed at N031 Industrial IOT and Remote O&M

Automation Revenues - $ millions - 2018
  Guide Control Measure    Air & Gases Measure  Liquids  Measure Powders
Pharmaceutical 1405 2972 468 468 402
Synthetic  1124 2378 374 374 322
Biopharmaceuticals   281 594 94 94 80
 

 January 23, 2019 - Modular Cleanrooms in Biopharmaceuticals

This webinar will focus on modular vs other cleanroom options as covered in N6F World Cleanroom Markets.  One of the biggest game changers for cleanroom companies could be a move to closed systems. The terms “single use” and “continuous processing” are used in conjunction with closed systems.  These terms can all be included under “biopharmaceutical manufacturing”.  The advantages over modular cleanrooms with open processing would be

  • Higher purity products with much less contamination potential
  • Less expensive to purchase and operate

However, there are a number of technology hurdles which make it likely that ISO 7 class cleanrooms will continue to play a large role even though there are isolators and restricted access barrier systems utilized in the space.  PODS or pre-fabricated cleanrooms are gaining market share along with modular cleanrooms.

Multiple options to approach a modular cleanroom project will be compared. The end user can deal with a modular room equipment company and contract separately for the construction and installation. Another option is a turnkey purchase with construction from a modular room supplier.  The third option is the use of a consultant or EPC who will supply the modular room and air related components such as HVAC but also the water for injection (WFI) and exhaust systems.  This could be part of a broader scope which includes all the processing systems within the room.

This webinar will analyze the technology drivers and the markets and will include presentations by cleanroom suppliers.  These presentations will be limited to 10 minutes but attendees will have access to more extensive recordings made in advance.  These should result in more meaningful discussions.

January 30, 2019 - Valve Options in Biopharmaceuticals

The present market for biopharmaceutical valves is in excess of $600 million/yr.  The design of valves must allow cleaning and sanitization between batches or maintenance intervals. Weir-type (as opposed to full bore) diaphragm valves are the mainstay for critical utilities and process applications. Ball valves typically are used for clean steam distribution and supply lines. These valves also are used in chemical and general purpose applications which do not require high levels of sterility or cleanability. The classification of valves and forecasts for each type are included in N028 Industrial Valves: World Market.

Where powders are involved split type butterfly valves allow transfer without exposure to the ambient air. There are valve designs for single use.  This webinar will provide market forecasts and include presentations by valve suppliers. These presentations will be limited to 10 minutes but attendees will have access to more extensive recordings made in advance.  These should result in more meaningful discussions.

February 6, 2019 - Pump Options in Biopharmaceuticals

The present market for biopharmaceutical pumps is in excess of $450 million/yr.  Pumps are needed to move fluids (e.g., buffer, media, and water for injection) through tubing and deliver them to the process equipment in batch type biopharmaceutical processes. Several types of positive displacement pumps are used, including peristaltic, diaphragm, rotary lobe, and gear pumps. The markets by pump type are displayed in N019 Pumps World Market.  A separate analysis of all products for water for injection (WFI) is covered in N029 Ultrapure Water: World Market.

This webinar will provide market forecasts and include presentations by pump suppliers. These presentations will be limited to 10 minutes but attendees will have access to more extensive recordings made in advance.  These should result in more meaningful discussions.

February 20, 2019 - Filtration Challenges in Biopharmaceuticals

Filter manufacturers have been challenged with increasing cell densities, greater expectations for viral clearance, and the desire of biopharmaceutical manufacturers to employ single-use technologies at an increasingly larger scale. They have responded with higher-capacity, higher-performance filters based on new materials, membrane structures, and filter designs.

Protein purification accounts for the largest share of the filtration market, but membrane filters for sterilization represent a fast growing segment.

The markets for three distinct segments: cross flow filtration as covered in the McIlvaine  N020 RO, UF, MF World Market, dead end filtration as covered in N024 Cartridge Filters: World Market, and macrofiltration as covered in N006 Liquid Filtration and Media World Markets.

This webinar will provide market forecasts and include presentations by filtration suppliers. These presentations will be limited to 10 minutes but attendees will have access to more extensive recordings made in advance.  These should result in more meaningful discussions.

March 6, 2019 - Centrifuge Options in Biopharmaceuticals

Centrifugation is used in a number of bioprocess applications, including clarification of solutions from hormone, vaccine, and enzyme production; bacterial culture harvest; and concentration and separation of blood fractions as covered in N005 Sedimentation and Centrifugation World Markets. Centrifuges used for such applications are tubular-bowl designs used in low volume processes, decanters used when feed-solids concentrations are high and disc-stack centrifuges. The market for centrifuges will be impacted by the trend to continuous processing and also the trend to single use where there are now centrifuge options. This webinar will provide market forecasts and include presentations by centrifuge suppliers. These presentations will be limited to 10 minutes but attendees will have access to more extensive recordings made in advance. These should result in more meaningful discussions.

Bob McIlvaine can answer your questions at This email address is being protected from spambots. You need JavaScript enabled to view it.   847 784 0012 ext. 122

You can register for the free webinars at  Free Market Webinars